Page 120 - Biomedical Engineering and Design Handbook Volume 2, Applications
P. 120

OVERVIEW OF CARDIOVASCULAR DEVICES  99

                          edition of this chapter from the Department of Energy under the Krell Institute’s Computational
                          Science Graduate Fellowship (CSGF).
                            This work was supported by the Department of Energy Computational Science Graduate
                          Fellowship Program of the Office of Science and National Nuclear Security Administration in the
                          Department of Energy under contract DE-FG02-97ER25308.




              REFERENCES

                          (1988). “Comparative evaluation of prosthetic, reversed, and in situ vein bypass grafts in distal popliteal and
                            tibial-peroneal revascularization.  Veterans  Administration Cooperative Study Group 141.”  Arch Surg,
                            123(4):434–8.
                          Abiomed Inc. (2007). “Heart Replacement.” Retrieved Jun 13, 2008, from http: //www.abiomed.com/products/heart
                            replacement.cfm.
                          Akins, C. W. (1995). “Results with mechanical cardiac valvular prostheses.” Ann Thorac Surg, 60(6):1836–44.
                          Al Suwaidi, J., P. B. Berger, et al. (2000). “Coronary artery stents.” JAMA, 284(14):1828–36.
                          Aldea, G. S., M. Doursounian, et al. (1996). “Heparin-bonded circuits with a reduced anticoagulation protocol in
                            primary CABG: a prospective, randomized study.” Ann Thorac Surg, 62(2):410–7; discussion 417–8.
                          Aldea, G. S., P. O’Gara, et al. (1998). “Effect of anticoagulation protocol on outcome in patients undergoing
                            CABG with heparin-bonded cardiopulmonary bypass circuits.” Ann Thorac Surg, 65(2):425–33.
                          Anderson, H. L., III and R. H. Bartlett (2000). Chapter 123: Extracorporeal life support for respiratory failure
                            and multiple organ failure. Textbook of Critical Care. A. Grenvik, S. M. Ayres, P. R. Holbrook and W. C.
                            Shoemaker. Philadelphia, PA. U.S.A., W. B. Saunders.
                          Anderson, H. V., R. E. Shaw, et al. (2002). “A contemporary overview of percutaneous coronary interventions.
                            The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).”  J Am  Coll
                            Cardiol, 39(7):1096–103.
                          Appelgren, P., U. Ransjo, et al. (1996). “Surface heparinization of central venous catheters reduces microbial col-
                            onization in vitro and in vivo: results from a prospective, randomized trial.” Crit Care Med, 24(9):1482–9.
                          Arafa, O. E., T. H. Pedersen, et al. (1999). “Vascular complications of the intraaortic balloon pump in patients
                            undergoing open heart operations: 15-year experience.” Ann Thorac Surg, 67(3):645–51.
                          Asimakopoulos, G., P. L. Smith, et al. (1999). “Lung injury and acute respiratory distress syndrome after car-
                            diopulmonary bypass.” Ann Thorac Surg, 68(3):1107–15.
                          Babaliaros, V. and P. Block (2007). “State of the art percutaneous intervention for the treatment of valvular heart
                            disease: a review of the current technologies and ongoing research in the field of percutaneous valve replace-
                            ment and repair.” Cardiology, 107(2):87–96.
                          Bagshaw, S. M., L. R. Berthiaume, et al. (2008). “Continuous versus intermittent renal replacement therapy for
                            critically ill patients with acute kidney injury: a meta-analysis.” Crit Care Med, 36(2):610–7.
                          Bai, J., H. Lin, et al. (1994). “A study of optimal configuration and control of a multi-chamber balloon for
                            intraaortic balloon pumping.” Ann Biomed Eng, 22(5):524–31.
                          Baldus, S., R. Koster, et al. (2000). “Treatment of aortocoronary vein graft lesions with membrane-covered stents:
                            A multicenter surveillance trial.” Circulation, 102(17):2024–7.
                          Bandyk, D. F. and G. E. Esses (1994). “Prosthetic graft infection.” Surg Clin North Am, 74(3):571–90.
                          Bartlett, R. H., D. W. Roloff, et al. (2000). “Extracorporeal life support: the University of Michigan experience.”
                            JAMA, 283(7):904–8.
                          Berger, K., L. R. Sauvage, et al. (1972). “Healing of arterial prostheses in man: its incompleteness.” Ann Surg,
                            175(1):118–27.
                          Bernstein, A. D., A. J. Camm, et al. (1993). “North American Society of Pacing and Electrophysiology policy
                            statement. The NASPE/BPEG defibrillator code.” Pacing Clin Electrophysiol, 16(9):1776–80.
                          Bernstein, A. D., A. J. Camm, et al. (1987). “The NASPE/BPEG generic pacemaker code for antibradyarrhyth-
                            mia and adaptive-rate pacing and antitachyarrhythmia devices.”  Pacing Clin Electrophysiol, 10(4 Pt 1):
                            794–9.
   115   116   117   118   119   120   121   122   123   124   125